HEOR Health Economics and Outcome Research

HEOR- Health Economics and Outcome Research

These days every pharmaceutical manufacturers and developers feel a tremendous pricing pressure and regulatory restrictions. That's why these pharmaceutical companies are approaching the clinical and economic evidence providers.

These stakeholders want to understand the product value completely, and it's potential to penetrate the market. For understanding real-world clinical practice, they have started relying on health economics and outcome research (HEOR) information. HEOR studies generate very useful data about the product which can advocate its easy market penetration.

HEOR generates the following data for the value proposition of individual product:
1. Clinical efficacy
2. Real-world data
3. Patient quality of life (QoL) reports
4. Budget impact models
5. Cost-effectiveness models

This data assist in the decision-making process.

The value proposition for market access of a product includes the following steps:
1. Value determination The clinical and economic value of the product under market access observation gets compared to the current benchmarks.
2. Value demonstration Economic models and clinical outcome research data are developed to demonstrate commercial and clinical elements for the target value proposition.
3. Value communication The value of the product is then informed to the relevant audience.
4. Value realization In this step, the price range is defined. This is a critical step for market access regarding reimbursement and seamless market penetration.
For further details visit:
www.heorgps.blospot.com
Also visit:
https://www.pharmahealthgps.com/
https://www.tendtothink.com/

Скачать видео